US2010159029A1PendingUtilityA1
Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response
Est. expiryDec 23, 2028(~2.4 yrs left)· nominal 20-yr term from priority
Inventors:John C. Lang
A61P 27/02A61K 31/07A61K 31/355A61K 31/593A23L 33/16A61K 31/592A23L 33/12A61K 33/34A23L 33/155A61K 31/202A61K 33/30A23V 2002/00A61K 31/375A23L 33/15
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides improved dietary supplements and methods for inhibiting the progression of macular degeneration and promoting healthy vision, while at the same time maintaining general health. The dietary supplements of the invention contain vitamin E and carotenoids in the form of lutein and/or zeaxanthine. The dietary supplements of the invention further contain Vitamin D, Vitamin C, copper and zinc and may also contain such ingredients as rosemary, DHA, and other vitamins and minerals.
Claims
exact text as granted — not AI-modified1 . A dietary supplement in the form of a softgel, comprising:
Amount per softgel
Ingredient
@ once per day
Lutein
10
mg
Zeaxanthin
2
mg
Vitamin C
80
mg
Vitamin E
12
mg
Copper
1
mg
Zinc
10
mg
Vitamin D
200
IU
Vitamin B1 (thiamin)
1.1
mg
Vitamin B2 (riboflavin)
1.4
mg
Vitamin B3 (niacin)
16
mg
Vitamin B6
1.4
mg
Folate/Folic Acid
200
μg
Vitamin B-12
25
μg
Selenium
55
μg
Manganese
2
mg
EPA
158
mg
DHA
83
mg
Water
TBD
wherein one supplement is ingested per day to provide the daily dosage amount.
2 . A method for reducing ocular inflammatory response, said method comprising administering to a patient in need thereof a dietary supplement in the form of a softgel comprising:
Lutein
10
mg
Zeaxanthin
2
mg
Vitamin C
80
mg
Vitamin E
12
mg
Copper
1
mg
Zinc
10
mg
Vitamin D
200
IU
Vitamin B1 (thiamin)
1.1
mg
Vitamin B2 (riboflavin)
1.4
mg
Vitamin B3 (niacin)
16
mg
Vitamin B6
1.4
mg
Folate/Folic Acid
200
μg
Vitamin B-12
25
μg
Selenium
55
μg
Manganese
2
mg
EPA
158
mg
DHA
83
mg
Water
TBD
wherein one softgel is ingested per day to provide the daily dosage amount.
3 . A method for reducing ocular inflammatory response, said method comprising administering to a patient in need thereof a dietary supplement in the form of a softgel comprising:
Lutein
10
mg
Zeaxanthin
2
mg
Vitamin C
80
mg
Vitamin E
12
mg
Copper
1
mg
Zinc
10
mg
Vitamin D
200
IU
Vitamin B1 (thiamin)
1.1
mg
Vitamin B2 (riboflavin)
1.4
mg
Vitamin B3 (niacin)
16
mg
Vitamin B6
1.4
mg
Folate/Folic Acid
200
μg
Vitamin B-12
25
μg
Selenium
55
μg
Manganese
2
mg
EPA
158
mg
DHA
83
mg
Water
TBD
wherein one softgel is ingested per day to provide the daily dosage amount.Join the waitlist — get patent alerts
Track US2010159029A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.